Tue. 19 Mar 2024, 4:12pm ET
Benzinga
Earnings, News
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 10.42 percent. This is a 70.97 percent decrease over losses of $(0.31) per share from the same period last year.